Éric Solary

42.3k total citations · 6 hit papers
369 papers, 21.5k citations indexed

About

Éric Solary is a scholar working on Molecular Biology, Hematology and Immunology. According to data from OpenAlex, Éric Solary has authored 369 papers receiving a total of 21.5k indexed citations (citations by other indexed papers that have themselves been cited), including 202 papers in Molecular Biology, 116 papers in Hematology and 83 papers in Immunology. Recurrent topics in Éric Solary's work include Acute Myeloid Leukemia Research (85 papers), Cell death mechanisms and regulation (69 papers) and Myeloproliferative Neoplasms: Diagnosis and Treatment (37 papers). Éric Solary is often cited by papers focused on Acute Myeloid Leukemia Research (85 papers), Cell death mechanisms and regulation (69 papers) and Myeloproliferative Neoplasms: Diagnosis and Treatment (37 papers). Éric Solary collaborates with scholars based in France, United States and Italy. Éric Solary's co-authors include Carmen Garrido, Arlette Hammann, François Martin, Bruno Chauffert, Yves Pommier, Nathalie Droin, Olivier Micheau, François Ghiringhelli, Marie‐Thérèse Dimanche‐Boitrel and E. Schmitt and has published in prestigious journals such as Nature, Journal of Biological Chemistry and Journal of Clinical Investigation.

In The Last Decade

Éric Solary

362 papers receiving 21.2k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Metronomic cyclophosphamide regimen selectively depletes CD4+CD25+ regulatory T cells and restores T and NK effector functions in end stage cancer patients

2006 968 citations François Ghiringhelli, S. Roux et al. profile →
Hsp27 negatively regulates cell death by interacting with cytochrome c

2000 814 citations Guido Kroemer, Éric Solary et al. profile →
CD4⁺CD25⁺ regulatory T cells suppress tumor immunity but are sensitive to cyclophosphamide which allows immunotherapy of established tumors to be curative

2004 706 citations François Ghiringhelli, E. Schmitt et al. profile →
Tumor cells convert immature myeloid dendritic cells into TGF-β–secreting cells inducing CD4 + CD25 + regulatory T cell proliferation

2005 588 citations François Ghiringhelli, S. Roux et al. The Journal of Experimental Medicine profile →
Improved management of invasive pulmonary aspergillosis in neutropenic patients using early thoracic computed tomographic scan and surgery.

1997 514 citations Éric Solary et al. profile →
Induction of a Common Pathway of Apoptosis by Staurosporine

1994 452 citations Éric Solary et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Éric Solary France	75	12.5k	5.3k	4.9k	3.5k	2.3k	369	21.5k
David C.S. Huang Australia	82	20.4k 1.6×	6.7k 1.3×	6.2k 1.3×	2.8k 0.8×	2.3k 1.0×	236	28.2k
Steven T. Pals Netherlands	71	9.6k 0.8×	6.2k 1.2×	5.0k 1.0×	2.0k 0.6×	2.1k 0.9×	238	20.9k
James A. McCubrey United States	79	16.1k 1.3×	3.2k 0.6×	6.8k 1.4×	2.6k 0.8×	1.6k 0.7×	421	24.9k
Kapil N. Bhalla United States	87	17.3k 1.4×	2.8k 0.5×	5.9k 1.2×	6.5k 1.9×	3.7k 1.6×	378	26.0k
Steven Grant United States	79	16.7k 1.3×	2.2k 0.4×	6.3k 1.3×	3.6k 1.0×	1.7k 0.7×	451	23.2k
Elisabeth Kremmer Germany	96	14.5k 1.2×	8.1k 1.5×	5.8k 1.2×	1.1k 0.3×	1.6k 0.7×	428	28.9k
Scott H. Kaufmann United States	95	25.8k 2.1×	4.2k 0.8×	11.9k 2.5×	3.2k 0.9×	2.1k 0.9×	406	36.2k
Atsushi Miyajima Japan	84	10.3k 0.8×	10.2k 1.9×	8.7k 1.8×	2.3k 0.6×	1.3k 0.6×	364	26.6k
Leonidas C. Platanias United States	76	9.0k 0.7×	7.4k 1.4×	6.9k 1.4×	2.4k 0.7×	1.4k 0.6×	340	18.6k
John L. Cleveland United States	78	14.8k 1.2×	4.7k 0.9×	6.8k 1.4×	1.6k 0.4×	1.1k 0.5×	224	22.7k

Countries citing papers authored by Éric Solary

Since Specialization

Citations

This map shows the geographic impact of Éric Solary's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Éric Solary with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Éric Solary more than expected).

Fields of papers citing papers by Éric Solary

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Éric Solary. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Éric Solary. The network helps show where Éric Solary may publish in the future.

Co-authorship network of co-authors of Éric Solary

This figure shows the co-authorship network connecting the top 25 collaborators of Éric Solary. A scholar is included among the top collaborators of Éric Solary based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Éric Solary. Éric Solary is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Onida, Francesco, Nico Gagelmann, Yves Chalandon, et al.. (2024). Management of adult patients with CMML undergoing allo-HCT: recommendations from the EBMT PH&G Committee. Blood. 143(22). 2227–2244. 8 indexed citations

Gilson, Éric, Pierre Soubeyran, & Éric Solary. (2024). Targeting Senescence for Next-Generation Cancer Treatments. Cancer Discovery. 14(4). 635–638. 5 indexed citations

Boutros, Michael, Michaël Baumann, Anna Bigas, et al.. (2024). UNCAN.eu: Toward a European Federated Cancer Research Data Hub. Cancer Discovery. 14(1). 30–35. 2 indexed citations

Pilot, Thomas, Stéphanie Solier, Charlène Magnani, et al.. (2023). Caspase 8-dependent inhibition of necroptosis prevents plaque necrotic core formation. Atherosclerosis. 379. S8–S9. 1 indexed citations

Botten, Giovanni A., Yuannyu Zhang, Yoon Jung Kim, et al.. (2023). Structural Variation Cooperates with Permissive Chromatin to Control Enhancer Hijacking-Mediated Oncogenic Transcription. Blood. 142(4). 336–351. 11 indexed citations

Solary, Éric, P. Blanc, Michael Boutros, et al.. (2022). UNCAN.eu, a European Initiative to UNderstand CANcer. Cancer Discovery. 12(11). 2504–2508. 2 indexed citations

Gao, Xin, Xiaona You, Nathalie Droin, et al.. (2022). Role of ASXL1 in hematopoiesis and myeloid diseases. Experimental Hematology. 115. 14–19. 15 indexed citations

Pronier, Elodie, Dorothée Selimoglu‐Buet, Raphaël Itzykson, et al.. (2022). Macrophage migration inhibitory factor is overproduced through EGR1 in TET2low resting monocytes. Communications Biology. 5(1). 110–110. 15 indexed citations

Coltro, Giacomo, Abhishek A. Mangaonkar, Terra L. Lasho, et al.. (2019). Clinical, molecular, and prognostic correlates of number, type, and functional localization of TET2 mutations in chronic myelomonocytic leukemia (CMML)—a study of 1084 patients. Leukemia. 34(5). 1407–1421. 63 indexed citations

10.

Antony‐Debré, Iléana, Nathalie Balayn, Dominique Bluteau, et al.. (2014). Level of RUNX1 activity is critical for leukemic predisposition but not for thrombocytopenia. Blood. 125(6). 930–940. 71 indexed citations

11.

Humbrecht, Catherine, Katy Billot, Virginie Mariot, et al.. (2013). Epigenetic Control of NF-κB-Dependent FAS Gene Transcription during Progression of Myelodysplastic Syndromes. Molecular Cancer Research. 11(7). 724–735. 15 indexed citations

12.

Colin, Didier, Emeric Limagne, Sylvie Jeanningros, et al.. (2011). Endocytosis of Resveratrol via Lipid Rafts and Activation of Downstream Signaling Pathways in Cancer Cells. Cancer Prevention Research. 4(7). 1095–1106. 85 indexed citations

13.

Jacquel, Arnaud, Nathalie Droin, Patrick Auberger, et al.. (2011). Leukemic cell xenograft in zebrafish embryo for investigating drug efficacy. Haematologica. 96(4). 612–616. 100 indexed citations

14.

Stefano, Antonio Di, Birgit Geoerger, Sofiane Hamidi, et al.. (2010). Monocytic cells derived from human embryonic stem cells and fetal liver share common differentiation pathways and homeostatic functions. Blood. 117(11). 3065–3075. 38 indexed citations

15.

Solary, Éric. (2006). La mort cellulaire induite par les agents cytotoxiques. Bulletin du Cancer. 93(4). 61–70. 1 indexed citations

16.

Cathelin, Séverine, Cédric Rébé, Frédèrique Verdier, et al.. (2006). Identification of Proteins Cleaved Downstream of Caspase Activation in Monocytes Undergoing Macrophage Differentiation. Journal of Biological Chemistry. 281(26). 17779–17788. 52 indexed citations

17.

Ghiringhelli, François, S. Roux, Arnaud Parcellier, et al.. (2005). Tumor cells convert immature myeloid dendritic cells into TGF-β–secreting cells inducing CD4 + CD25 + regulatory T cell proliferation. The Journal of Experimental Medicine. 202(7). 919–929. 588 indexed citations breakdown →

18.

Filomenko, Rodolphe, et al.. (2002). Atypical protein kinase C zeta as a target for chemosensitization of tumor cells.. PubMed. 62(6). 1815–21. 32 indexed citations

19.

Micheau, Olivier, Éric Solary, Arlette Hammann, & Marie‐Thérèse Dimanche‐Boitrel. (1999). Fas Ligand-independent, FADD-mediated Activation of the Fas Death Pathway by Anticancer Drugs. Journal of Biological Chemistry. 274(12). 7987–7992. 266 indexed citations

20.

Quantin, Catherine, Michał Abrahamowicz, Lionel Mannone, et al.. (1999). Testing the proportional hazards assumption in medical survival studies--application to a population-based study of acute myeloid leukaemia.. PubMed. 4(2). 83–92. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact